Transport of pyruvate nad lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier
- 14 May 1976
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 156 (2) , 193-207
- https://doi.org/10.1042/bj1560193
Abstract
The kinetics and activation energy of entry of pyruvate and lactate into the erythrocyte were studied at concentrations below 4 and 15mM respectively. The Km and Vmax. values for both substrates are reported, and it is shown that pyruvate inhibits competitively with respect to lactate and vice versa. In both cases the Km for the carboxylate as a substrate was the same as its Ki as an inhibitor. α-Cyano-4-hydroxycinnamate and its analogues inhibited the uptake of both lactate and pyruvate competitively. Inhibition was also produced by treatment of cells with fluorodinitrobenzene but not with the thiol reagents or Pronase. At high concentrations of pyruvate or lactate (20mM), uptake of the carboxylate was accompanied by an efflux of Cl-ions. This efflux of Cl- was inhibited by α-cyano-4-hydroxycinnamate and picrate and could be totally abolished by very low (< 10 µM) concentrations of the inhibitor of Cl- transport, 4,4'-di-isothiocyanostilbene-2,2'-disulphonic acid. This inhibitor titrated out the chlordie efflux induced by pyruvate, bicarbonate, formate and fluoride, in each case total inhibition becoming apparent when approximately 1.2 × 106 molecules of inhibitor were present per erythrocyte, that is, about one inhibitor molecule per molecule of the Cl- carrier. Evan when Cl- efflux was totally blocked pyruvate and lactate uptake occurred. Kinetic evidence is presented which suggests that the Cl- carrier can transport pyruvate and lactate with a high Km and high Vmax., but that an additional carrier with a low Km and a low Vmax. also exists. This carrier catalyses the exchange of small carboxylate anions with intracellular lactate, is competitively inhibited by α-cyano-4-hydroxycinnamate and non-competitively inhibited by picrate. The Cl- carrier shows a reverse pattern of inhibition. It is concluded that net efflux of lactic acid from the cell must occur on the Cl- carrier and involve exchange with HCO3- followed by loss of CO2. The low Km carrier might be used in pyruvate/lactate or acetoacetate/β-hydroxybutyrate exchanges involved in transferring reducing power across the cell membrane. The possibility that the Cl- carrier exists in cells other than the erythrocyte is discussed. It is concluded that its presence in other cell membranes together with a low intracellular Cl- concentration would explain why the pH in the cytoplasm is lower than that of the blood, and why permeable carboxylate anions do not accumulate within the cell when added from outside.This publication has 37 references indexed in Scilit:
- Inhibition of mitochondrial pyruvate transport by phenylpyruvate and α-ketoisocaproateBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- Topographical Distribution of Complex Carbohydrates in the Erythrocyte MembraneJournal of Biological Chemistry, 1974
- Effect of some monovalent anions on chloride and sulphate permeability of human red cellsThe Journal of Physiology, 1970
- Intracellular Acid-Base Regulation. I. The Response of Muscle Cells to Changes in CO2 Tension or Extracellular Bicarbonate Concentration *Journal of Clinical Investigation, 1965
- A fluorescent label for the outer components of the plasma membraneBiochimica et Biophysica Acta (BBA) - Specialized Section on Biophysical Subjects, 1964
- [THE EFFECT OF CARBON DIOXIDE PRESSURE ON THE INTERSTITIAL PH OF THE ISOLATED RAT DIAPHRAGM].1964
- The kinetics of enzyme-catalyzed reactions with two or more substrates or products☆II. Inhibition: Nomenclature and theoryBiochimica et Biophysica Acta, 1963
- Contractility and sugar permeability in the perfused rat heartThe Journal of Physiology, 1961
- Chloride ions and the membrane potential of Purkinje fibresThe Journal of Physiology, 1961
- CALCULATION OF INTRACELLULAR pH FROM THE DISTRIBUTION OF 5,5-DIMETHYL-2,4-OXAZOLIDINEDIONE (DMO). APPLICATION TO SKELETAL MUSCLE OF THE DOG*Journal of Clinical Investigation, 1959